Veterinary Medicines

Advantage Dog 40 40 mg/0.4 ml Oplossing voor cutaan gebruik

Authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Advantage Dog 40 40 mg/0.4 ml Oplossing voor cutaan gebruik
Advantage Dog 40 40 mg/0.4 ml Solution pour application cutanée
Advantage Dog 40 40 mg/0.4 ml Lösung zur Anwendung auf der Haut
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Advantage Dog 40 6 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 4 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 3 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 2 Pipettes with 0.4 ml Cutaneous solution

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed Consent application (Article 21 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V459680
Date of authorisation status change:
Informed consent reference:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."